SOP for Global Reuse of Core CMC Documentation


Regulatory Affairs: SOP for Global Reuse of Core CMC Documentation – V 1.0

Standard Operating Procedure for Global Reuse of Core CMC Documentation

Department Regulatory Affairs
SOP No. RA/2026/716
Supersedes NA
Page No. 1 of X
Issue Date 13/04/2026
Effective Date 13/04/2026
Review Date 13/04/2028

Purpose

This standard operating procedure (SOP) defines the systematic approach and control measures for the global reuse of core Chemistry, Manufacturing, and Controls (CMC) documentation to ensure regulatory compliance, consistency, and efficiency in dossier submissions across multiple regions. The SOP supports the objective of harmonizing documentation practices, maintaining data integrity, and minimizing redundancy in regulatory submissions while adhering to applicable regulatory guidelines and internal quality standards.

Scope

This SOP applies to all activities related to preparation, review, approval, storage, and reuse of core CMC documentation for regulatory submissions across all functional areas involved in regulatory affairs globally. It covers documentation related to product composition, manufacturing processes, quality controls, stability data, and related technical dossiers for all dosage forms and pharmaceutical products managed by the organization. Excluded are documents outside core CMC scope such as clinical trial data, pharmacovigilance reports, or non-regulatory internal communications.

Responsibilities

The following functional roles are involved:

  • Regulatory Affairs Specialists: Prepare, compile, and submit CMC documents for global reuse.
  • Regulatory Affairs Reviewers: Review and verify accuracy and compliance of reused documents.
  • Quality Assurance: Oversee adherence to quality systems and audit readiness of documentation.
  • Document Control Personnel: Manage version control, document archiving, and accessibility.
  • Subject Matter Experts (SMEs): Provide technical inputs and validation of CMC content.
See also  SOP for Registration Renewal Planning and Execution

Accountability

The Head of Regulatory Affairs is accountable for ensuring effective implementation, compliance, periodic review, necessary training, and escalation for this SOP. They are responsible for oversight on quality and regulatory adherence, ensuring amendments to the SOP are conducted timely, and monitoring its effectiveness during audits and inspections.

Procedure

1. Preparation and Prerequisites:

Identify core CMC documents qualified for global reuse by confirming data validity and regulatory acceptance in target regions. Ensure supporting data such as validation reports, batch records, and analytical data are complete and current.

2. Safety and GMP Considerations:

Verify all documents maintain compliance with GMP principles and do not disclose confidential or region-specific proprietary information that could compromise regulatory obligations or intellectual property.

3. Document Review and Verification:

Regulatory Affairs Reviewers shall conduct thorough checks against applicable regional regulatory guidelines to confirm that reused core documents align with dossier requirements. Discrepancies, outdated information, or non-compliance must be flagged for correction.

4. Approval and Authorization:

Following review, documents must be approved by authorized personnel including SMEs and Regulatory Affairs leadership. Approval must be documented with signatures, dates, and version numbers maintained in the document control system.

5. Dossier Integration and Tracking:

Incorporate approved core CMC documents into submission dossiers using controlled templates ensuring consistency in formatting and numbering. Maintain a reuse tracking log capturing document versions, reuse locations, justification, and regulatory submission references.

6. Record Retention and Archiving:

All original and reused core CMC documents shall be archived securely per regulatory record retention policies. Electronic records must follow validated systems with access controls and audit trails.

7. Handling Deviations and Amendments:

See also  SOP for CMC Deficiency Prevention Before Filing

Deviations identified post reuse must be documented, investigated, and reported per established change control processes. Amendments to core documents require re-approval and communication across all impacted regions.

8. Training and Communication:

Personnel involved in global reuse must undergo training on this SOP and regulatory expectations. Changes to the SOP or document templates must be communicated promptly to all relevant stakeholders.

9. Periodic Review:

This procedure shall be reviewed at least biennially or upon significant regulatory changes to ensure continued applicability and effectiveness.

Abbreviations

CMC – Chemistry, Manufacturing, and Controls
GMP – Good Manufacturing Practices
SOP – Standard Operating Procedure
SME – Subject Matter Expert
QA – Quality Assurance

Documents

  1. Core CMC Documentation Approval Form (Annexure-1)
  2. Core CMC Document Reuse Tracking Log (Annexure-2)
  3. Training Acknowledgement Form for Global Documentation Reuse (Annexure-3)

References

International Council for Harmonisation (ICH) Guidelines Q7 and M4
FDA Guidance for Industry on CMC Information
European Medicines Agency (EMA) Regulatory Guidance on Dossier Content
ICH Q10 Pharmaceutical Quality System
Internal Document Control and Change Management Procedures

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Core CMC Documentation Approval Form

Purpose: To document the formal approval of core CMC documents intended for global reuse in regulatory submissions.

Document Title Product Stability Summary Report
Document Number CMC-STR-2026-04
Version 2.1
Prepared By Regulatory Affairs Specialist
Reviewed By Quality Assurance Reviewer
SME Consultation Completed – 05/04/2026
Approval Date 10/04/2026
Effective Date 13/04/2026
Comments Document meets all regional requirements and is cleared for global reuse.
Authorized Signatures

Annexure-2: Core CMC Document Reuse Tracking Log

Purpose: To track instances of reuse of core CMC documentation across global submissions, ensuring traceability and version control.

Document Title Document No. Version Reuse Location Submission Date Regulatory Authority Remarks
Product Stability Summary Report CMC-STR-2026-04 2.1 Region APAC 15/04/2026 Health Authority APAC No deviations
Product Stability Summary Report CMC-STR-2026-04 2.1 Region EU 20/04/2026 EMA Updated annex included
See also  SOP for Submission Calendar Control and Deadline Monitoring

Annexure-3: Training Acknowledgement Form for Global Documentation Reuse

Purpose: To document personnel acknowledgment of training on SOP procedures related to global reuse of core CMC documentation.

Training Title SOP for Global Reuse of Core CMC Documentation
Training Date 12/04/2026
Location Virtual / Headquarters
Participant Name [Employee ID]
Department Regulatory Affairs
Acknowledgement I confirm that I have completed the training and understand the procedures for global reuse of core CMC documentation.
Signature
Date 12/04/2026

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
13/04/2026 1.0 Initial issue New SOP creation